Acorda Neurological Therapy Products and Clinical Research

Bill Dollard

"The most rewarding part of my job is when we hear from patients. You see that what we're doing is really helping them."

Employee since 2002
Technical Operations

Therapies developed on a foundation of experience

We have a deep understanding of - and experience in - nervous system research, product development and commercialization. This expertise enables us to focus on therapies that have a potential to improve the lives of people with neurological disorders. In this section you can learn more about our pipeline programs, as well as our approved products.

Product Pipeline

We’re dedicated to the development and commercialization of novel therapies to improve, repair and restore neurological function in people with a range of nervous system disorders, including Parkinson’s disease and multiple sclerosis.

LEARN MORE

AMPYRA® (dalfampridine)

INBRIJA™ (levodopa inhalation powder)

Pipeline

You are now leaving the Acorda.com site. By clicking "Ok", you will be leaving this website (sponsored by Acorda Therapeutics, Inc.) to enter an external and entirely independent website.

Acorda.com provides this link as a service and assumes no responsibility for any information presented on external websites.

If you’ve been impacted by Hurricane Harvey, Irma, or Maria, and have concerns about your Ampyra (dalfampridine) prescription, please contact your Specialty Pharmacy or Ampyra Patient Support Services at (888) 881-1918

Acorda has acquired Biotie Therapies. We invite you to explore www.acorda.com to learn more about our company, including our continued development of BIotie clinical programs for tozadenant, SYN120 and BTT1023. Information regarding transfers of value made to healthcare professionals and healthcare organizations in connection with Biotie’s clinical development programs is also available.

The website uses cookies, which are text files placed on your computer. Some of these are essential to the site’s operation while others analyse how visitors use the site. These cookies are set by default but you can disable them or view more information about how they are used here. By clicking on continue you consent to our use of cookies.